Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease

被引：1
|
作者：
Chang, Hui-Chin [1 ,2 ,3 ]
Gau, Shuo-Yan [3 ,4 ,5 ]
机构：
[1] Chung Shan Med Univ Hosp, Lib, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Evidence Based Med Ctr, Taichung, Taiwan
[3] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[4] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan
[5] Chung Shan Med Univ, Sch Med, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan
来源：
AMERICAN JOURNAL OF MEDICINE | 2024年 / 137卷 / 01期
关键词：
RISK;
D O I：
10.1016/j.amjmed.2023.07.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E14 / E14
页数：1
相关论文
共 50 条
  • [1] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply
    Yeoh, Aaron
    Cheung, Ramsey
    Ahmed, Aijaz
    Chitnis, Amit S.
    Do, Albert
    Wong, Robert J.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E15 - E15
  • [2] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    [J]. LIVER INTERNATIONAL, 2024,
  • [3] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    [J]. HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [4] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    [J]. Cardiovascular Diabetology, 21
  • [6] Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Jeong, Seogsong
    Oh, Yun Hwan
    Choi, Seulggie
    Chang, Jooyoung
    Kim, Sung Min
    Son, Joung Sik
    Lee, Gyeongsil
    Kim, Won
    Park, Sang Min
    [J]. GUT AND LIVER, 2021, : 589 - 598
  • [7] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [8] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [9] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    [J]. Hepatology International, 2023, 17 : 626 - 635
  • [10] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
12345